CLDN1 and metabolic dysfunction-associated steatotic liver disease: These findings indicate that GLC administration effectively ameliorates the loss of integrity of the intestinal mucosal barrier in HFHSD-fed NAFLD mice by increasing the expression of Claudin-1.